Minghua Ren
5PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 10, 2026
APOBEC3C Suppresses Prostate Cancer by Regulating Key Molecules Involved in Cellular Inflammation, Cell Cycle Arrest, and DNA Damage Response.Zhongqi Pang, Jianshe Wang, Yidan Xu
|Jul 13, 2024
Correction: Liu et al. Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer. J. Clin. Med. 2023, 12, 1861.Yang Liu, Chang-Lin Wang, Zhong-Qi Pang
|Mar 11, 2023
Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer.Yang Liu, Chang-Lin Wang, Zhong-Qi Pang
|Dec 23, 2022
Cathepsins Trigger Cell Death and Regulate Radioresistance in Glioblastoma.Xiaofeng Ding, Chen Zhang, Huajian Chen
|Feb 22, 2021
Furazolidone Increases Survival of Mice Exposed to Lethal Total Body Irradiation through the Antiapoptosis and Antiautophagy Mechanism.Shumei Ma, Zhao Jin, Yi Liu
Pageof 1
